Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial

Abstract Background Venetoclax (Ven) combined with intensive chemotherapy was proven effective in the management of acute myeloid leukemia (AML). However, the severe and prolonged myelosuppression remains a concern to worry about. To explore more appropriate combination regimens, we designed Ven com...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Xiaohui Suo, Fang Zheng, Dongmei Wang, Liyun Zhao, Jie Liu, Ling Li, Zhihua Zhang, Congcong Zhang, Yinling Li, Sisi Yang, Xuemei Zhao, Rui Shi, Yan Wu, Zongjiu Jiao, Jiaojie Song, Ling Zhang, Xinxiao Lu, Linyu Yuan, Sifeng Gao, Jilei Zhang, Xingli Zhao, Guanchen Bai, Kaiqi Liu, Yingchang Mi
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2023-05-01
Reeks:	Experimental Hematology & Oncology
Onderwerpen:	Venetoclax DA Induction treatment Acute myeloid leukemia
Online toegang:	https://doi.org/10.1186/s40164-023-00409-y
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!